abstract |
The present invention describes semi-solid pharmaceutical compositions containing pirfenidone which, due to its osmotic and absorption properties, offer advantages over other dermally administered pharmaceutical forms known in the prior art for use in the treatment of restoring tissue that has been subject to extracellular matrix loss or degradation that results in the formation of wrinkles or thinning of the skin. |